Literature DB >> 15222737

Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves.

M S Dardi1, S K Sharma, A K Srivastava.   

Abstract

The pharmacokinetics and dosage regimen of ceftriaxone were investigated in buffalo calves (n = 6) following a single intravenous administration of ceftriaxone (10 mg/kg). The elimination rate constant was 0.18 +/- 0.01 h(-1) and the elimination half-life was 3.79 +/- 0.09 h. The apparent volume of distribution (Vd(area)) was 1.40 +/- 0.01 L/kg and the total plasma clearance was 0.26 +/- 0.01 L/(kg h). Approximately 43% of total administered dose of ceftriaxone was excreted in urine within 8 h. To maintain a minimum therapeutic concentration of 1 microg/ml, a satisfactory intravenous dosage regimen of ceftriaxone in buffalo calves is 13 mg/kg repeated at 12 h intervals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222737     DOI: 10.1023/b:verc.0000026658.45361.ce

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  11 in total

1.  Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs.

Authors:  M Rebuelto; G Albarellos; L Ambros; V Kreil; L Montoya; R Bonafine; P Otero; R Hallu
Journal:  J Vet Pharmacol Ther       Date:  2002-02       Impact factor: 1.786

2.  Pharmacokinetics of ceftriaxone in healthy horses.

Authors:  N C Ringger; E G Pearson; R Gronwall; S J Kohlepp
Journal:  Equine Vet J       Date:  1996-11       Impact factor: 2.888

3.  Disposition of ceftriaxone in rat: application of a pharmacokinetic-protein binding model and comparison with cefotaxime.

Authors:  L Hakim; D W Bourne; E J Triggs
Journal:  Xenobiotica       Date:  1989-08       Impact factor: 1.908

4.  Pharmacokinetics of ceftriaxone in mares.

Authors:  S Y Gardner; D P Aucoin
Journal:  J Vet Pharmacol Ther       Date:  1994-04       Impact factor: 1.786

5.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

6.  Disposition kinetics and dosage regimen of ceftriaxone in crossbred calves (short communication).

Authors:  B Johal; A K Srivastava
Journal:  Acta Vet Hung       Date:  1999       Impact factor: 0.955

7.  Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly to calves.

Authors:  S Soback; G Ziv
Journal:  Am J Vet Res       Date:  1988-04       Impact factor: 1.156

8.  Pharmacokinetics and serum concentrations of cephapirin in neonatal foals.

Authors:  M P Brown; R Gronwall; T B Gossman; A E Houston
Journal:  Am J Vet Res       Date:  1987-05       Impact factor: 1.156

9.  Cefodizime, an aminothiazolylcephalosporin. II. Comparative studies on the pharmacokinetic behavior in laboratory animals.

Authors:  N Klesel; M Limbert; K Seeger; G Seibert; I Winkler; E Schrinner
Journal:  J Antibiot (Tokyo)       Date:  1984-08       Impact factor: 2.649

10.  Pharmacokinetics and body fluid and endometrial concentrations of cephapirin in mares.

Authors:  M P Brown; R R Gronwall; A E Houston
Journal:  Am J Vet Res       Date:  1986-04       Impact factor: 1.156

View more
  3 in total

1.  Plasma pharmacokinetics and milk levels of ceftriaxone following single intravenous administration in healthy and endometritic cows.

Authors:  Sudershan Kumar; Anil K Srivastava; V K Dumka; Naresh Kumar; Rajinder K Raina
Journal:  Vet Res Commun       Date:  2010-06-24       Impact factor: 2.459

2.  Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves.

Authors:  Neetu Rajput; Vinod K Dumka; Harpal S Sandhu
Journal:  J Vet Sci       Date:  2007-03       Impact factor: 1.672

3.  Potential of a polyherbal drug to prevent antimicrobial resistance in bacteria to antibiotics.

Authors:  Tapas Kumar Sar; Indranil Samanta; Achintya Mahanti; Shabnam Akhtar; Jeevan Ranjan Dash
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.